EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Management of Iron Deficiency in Heart Failure

Kazuhiko Kido, Craig J Beavers, Kenneth Dulnuan, Nadia Fida, Maya Guglin, Onyedika J Ilonze, Robert J Mentz, Nikhil Narang, Navin Rajagopalan, Bhavadharini Ramu, Yasar Sattar, George Sokos und 1 weitere

JACC: Heart Failure · 2024

DOI: 10.1016/j.jchf.2024.05.014 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift JACC: Heart Failure, 2024. Verfasst von Kazuhiko Kido und 12 weiteren Autor:innen. Beteiligte Einrichtung: West Virginia University School of Pharmacy, Morgantown, West Virginia, USA. Electronic address: kazuhiko.kido0322@gmail.com. Hauptthemen laut MEDLINE: Heart Failure, Anemia, Iron-Deficiency. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 68 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Iron deficiency (ID) is present in approximately 50% of patients with heart failure (HF) and even higher prevalence rate up to 80% in post-acute HF setting. The current guidelines for HF recommend intravenous (IV) iron replacement in HF with reduced or mildly reduced ejection fraction and ID based on clinical trials showing improvements in quality of life and exercise capacity, and an overall treatment benefit for recurrent HF hospitalization. However, several barriers cause challenges in implementing IV iron supplementation in practice due, in part, to clinician knowledge gaps and limited resource availability to protocolize routine utilization in appropriate patients. Thus, the current review will discuss practical considerations in ID treatment, implementation of evidence-based ID treatment to improve regional health disparities with toolkits, inclusion/exclusion criteria of IV iron supplementation, and clinical controversies in ID treatment, as well as gaps in evidence and questions to be answered.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureAnemia, Iron-DeficiencyHumansIronEvidence-Based MedicineDietary SupplementsStroke VolumeIron DeficienciesQuality of LifePractice Guidelines as Topic

Stichwörter der Autor:innen

anemiaferric carboxymaltoseheart failureimplementationintravenous ironironiron sucrose

Substanzen

Iron

Autor:innen und Institutionen

  • West Virginia University School of Pharmacy, Morgantown, West Virginia, USA. Electronic address: kazuhiko.kido0322@gmail.com.
  • University of Kentucky College of Pharmacy, Lexington, Kentucky, USA.
  • Robert Wood Johnson University Hospital, New Brunswick, New Jersey, USA.
  • Houston Methodist, Houston, Texas, USA.
  • Krannert Cardiovascular Research Center, Indiana University Health School of Medicine, Indianapolis, Indiana, USA.
  • Division of Cardiovascular Medicine, Krannert Cardiovascular Research Center, Indiana University, Indianapolis, Indiana, USA.

Zitieren

APA

Kido, K., Beavers, C. J., Dulnuan, K., Fida, N., Guglin, M., Ilonze, O. J., Mentz, R. J., Narang, N., Rajagopalan, N., Ramu, B., Sattar, Y., Sokos, G., & Jankowska, E. A. (2024). Management of Iron Deficiency in Heart Failure. JACC: Heart Failure. https://doi.org/10.1016/j.jchf.2024.05.014

Vancouver

Kido K, Beavers CJ, Dulnuan K, Fida N, Guglin M, Ilonze OJ, et al. Management of Iron Deficiency in Heart Failure. JACC: Heart Failure. 2024. doi:10.1016/j.jchf.2024.05.014

BibTeX
@article{Kido2024,
  author = {Kido, Kazuhiko and Beavers, Craig J and Dulnuan, Kenneth and Fida, Nadia and Guglin, Maya and Ilonze, Onyedika J and Mentz, Robert J and Narang, Nikhil and Rajagopalan, Navin and Ramu, Bhavadharini and Sattar, Yasar and Sokos, George and Jankowska, Ewa A},
  title = {Management of Iron Deficiency in Heart Failure},
  journal = {JACC: Heart Failure},
  year = {2024},
  doi = {10.1016/j.jchf.2024.05.014}
}
Kostenlos starten →